 | • レポートコード：MRC2-11QY10933 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は自家幹細胞ベース治療法のグローバル市場について調査・分析したレポートです。種類別（胚性幹細胞、常在心臓幹細胞、臍帯血幹細胞）市場規模、用途別（神経変性疾患、自己免疫疾患、心血管疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別自家幹細胞ベース治療法の競争状況、市場シェア ・世界の自家幹細胞ベース治療法市場：種類別市場規模 2015年-2020年（胚性幹細胞、常在心臓幹細胞、臍帯血幹細胞） ・世界の自家幹細胞ベース治療法市場：種類別市場規模予測 2021年-2026年（胚性幹細胞、常在心臓幹細胞、臍帯血幹細胞） ・世界の自家幹細胞ベース治療法市場：用途別市場規模 2015年-2020年（神経変性疾患、自己免疫疾患、心血管疾患） ・世界の自家幹細胞ベース治療法市場：用途別市場規模予測 2021年-2026年（神経変性疾患、自己免疫疾患、心血管疾患） ・北米の自家幹細胞ベース治療法市場分析：米国、カナダ ・ヨーロッパの自家幹細胞ベース治療法市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの自家幹細胞ベース治療法市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の自家幹細胞ベース治療法市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの自家幹細胞ベース治療法市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Regeneus、Mesoblast、Pluristem Therapeutics Inc、US STEM CELL, INC.、Brainstorm Cell Therapeutics、Tigenix、Med cell Europe ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Autologous Stem Cell Based Therapies Market
The global Autologous Stem Cell Based Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Autologous Stem Cell Based Therapies Scope and Market Size
Autologous Stem Cell Based Therapies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Autologous Stem Cell Based Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Regeneus
Mesoblast
Pluristem Therapeutics Inc
US STEM CELL, INC.
Brainstorm Cell Therapeutics
Tigenix
Med cell Europe
…
Market segment by Type, the product can be split into
Embryonic Stem Cell
Resident Cardiac Stem Cells
Umbilical Cord Blood Stem Cells
Market segment by Application, split into
Neurodegenerative Disorders
Autoimmune Diseases
Cardiovascular Diseases
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Autologous Stem Cell Based Therapies Revenue
1.4 Market by Type
1.4.1 Global Autologous Stem Cell Based Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Embryonic Stem Cell
1.4.3 Resident Cardiac Stem Cells
1.4.4 Umbilical Cord Blood Stem Cells
1.5 Market by Application
1.5.1 Global Autologous Stem Cell Based Therapies Market Share by Application: 2020 VS 2026
1.5.2 Neurodegenerative Disorders
1.5.3 Autoimmune Diseases
1.5.4 Cardiovascular Diseases
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Autologous Stem Cell Based Therapies Market Perspective (2015-2026)
2.2 Global Autologous Stem Cell Based Therapies Growth Trends by Regions
2.2.1 Autologous Stem Cell Based Therapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Autologous Stem Cell Based Therapies Historic Market Share by Regions (2015-2020)
2.2.3 Autologous Stem Cell Based Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Autologous Stem Cell Based Therapies Market Growth Strategy
2.3.6 Primary Interviews with Key Autologous Stem Cell Based Therapies Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Autologous Stem Cell Based Therapies Players by Market Size
3.1.1 Global Top Autologous Stem Cell Based Therapies Players by Revenue (2015-2020)
3.1.2 Global Autologous Stem Cell Based Therapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Autologous Stem Cell Based Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Autologous Stem Cell Based Therapies Market Concentration Ratio
3.2.1 Global Autologous Stem Cell Based Therapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Autologous Stem Cell Based Therapies Revenue in 2019
3.3 Autologous Stem Cell Based Therapies Key Players Head office and Area Served
3.4 Key Players Autologous Stem Cell Based Therapies Product Solution and Service
3.5 Date of Enter into Autologous Stem Cell Based Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Autologous Stem Cell Based Therapies Historic Market Size by Type (2015-2020)
4.2 Global Autologous Stem Cell Based Therapies Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Autologous Stem Cell Based Therapies Market Size by Application (2015-2020)
5.2 Global Autologous Stem Cell Based Therapies Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Autologous Stem Cell Based Therapies Market Size (2015-2020)
6.2 Autologous Stem Cell Based Therapies Key Players in North America (2019-2020)
6.3 North America Autologous Stem Cell Based Therapies Market Size by Type (2015-2020)
6.4 North America Autologous Stem Cell Based Therapies Market Size by Application (2015-2020)
7 Europe
7.1 Europe Autologous Stem Cell Based Therapies Market Size (2015-2020)
7.2 Autologous Stem Cell Based Therapies Key Players in Europe (2019-2020)
7.3 Europe Autologous Stem Cell Based Therapies Market Size by Type (2015-2020)
7.4 Europe Autologous Stem Cell Based Therapies Market Size by Application (2015-2020)
8 China
8.1 China Autologous Stem Cell Based Therapies Market Size (2015-2020)
8.2 Autologous Stem Cell Based Therapies Key Players in China (2019-2020)
8.3 China Autologous Stem Cell Based Therapies Market Size by Type (2015-2020)
8.4 China Autologous Stem Cell Based Therapies Market Size by Application (2015-2020)
9 Japan
9.1 Japan Autologous Stem Cell Based Therapies Market Size (2015-2020)
9.2 Autologous Stem Cell Based Therapies Key Players in Japan (2019-2020)
9.3 Japan Autologous Stem Cell Based Therapies Market Size by Type (2015-2020)
9.4 Japan Autologous Stem Cell Based Therapies Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Autologous Stem Cell Based Therapies Market Size (2015-2020)
10.2 Autologous Stem Cell Based Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Autologous Stem Cell Based Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Autologous Stem Cell Based Therapies Market Size by Application (2015-2020)
11 India
11.1 India Autologous Stem Cell Based Therapies Market Size (2015-2020)
11.2 Autologous Stem Cell Based Therapies Key Players in India (2019-2020)
11.3 India Autologous Stem Cell Based Therapies Market Size by Type (2015-2020)
11.4 India Autologous Stem Cell Based Therapies Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Autologous Stem Cell Based Therapies Market Size (2015-2020)
12.2 Autologous Stem Cell Based Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Autologous Stem Cell Based Therapies Market Size by Type (2015-2020)
12.4 Central & South America Autologous Stem Cell Based Therapies Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Regeneus
13.1.1 Regeneus Company Details
13.1.2 Regeneus Business Overview
13.1.3 Regeneus Autologous Stem Cell Based Therapies Introduction
13.1.4 Regeneus Revenue in Autologous Stem Cell Based Therapies Business (2015-2020))
13.1.5 Regeneus Recent Development
13.2 Mesoblast
13.2.1 Mesoblast Company Details
13.2.2 Mesoblast Business Overview
13.2.3 Mesoblast Autologous Stem Cell Based Therapies Introduction
13.2.4 Mesoblast Revenue in Autologous Stem Cell Based Therapies Business (2015-2020)
13.2.5 Mesoblast Recent Development
13.3 Pluristem Therapeutics Inc
13.3.1 Pluristem Therapeutics Inc Company Details
13.3.2 Pluristem Therapeutics Inc Business Overview
13.3.3 Pluristem Therapeutics Inc Autologous Stem Cell Based Therapies Introduction
13.3.4 Pluristem Therapeutics Inc Revenue in Autologous Stem Cell Based Therapies Business (2015-2020)
13.3.5 Pluristem Therapeutics Inc Recent Development
13.4 US STEM CELL, INC.
13.4.1 US STEM CELL, INC. Company Details
13.4.2 US STEM CELL, INC. Business Overview
13.4.3 US STEM CELL, INC. Autologous Stem Cell Based Therapies Introduction
13.4.4 US STEM CELL, INC. Revenue in Autologous Stem Cell Based Therapies Business (2015-2020)
13.4.5 US STEM CELL, INC. Recent Development
13.5 Brainstorm Cell Therapeutics
13.5.1 Brainstorm Cell Therapeutics Company Details
13.5.2 Brainstorm Cell Therapeutics Business Overview
13.5.3 Brainstorm Cell Therapeutics Autologous Stem Cell Based Therapies Introduction
13.5.4 Brainstorm Cell Therapeutics Revenue in Autologous Stem Cell Based Therapies Business (2015-2020)
13.5.5 Brainstorm Cell Therapeutics Recent Development
13.6 Tigenix
13.6.1 Tigenix Company Details
13.6.2 Tigenix Business Overview
13.6.3 Tigenix Autologous Stem Cell Based Therapies Introduction
13.6.4 Tigenix Revenue in Autologous Stem Cell Based Therapies Business (2015-2020)
13.6.5 Tigenix Recent Development
13.7 Med cell Europe
13.7.1 Med cell Europe Company Details
13.7.2 Med cell Europe Business Overview
13.7.3 Med cell Europe Autologous Stem Cell Based Therapies Introduction
13.7.4 Med cell Europe Revenue in Autologous Stem Cell Based Therapies Business (2015-2020)
13.7.5 Med cell Europe Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Autologous Stem Cell Based Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Autologous Stem Cell Based Therapies Revenue
Table 3. Ranking of Global Top Autologous Stem Cell Based Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Autologous Stem Cell Based Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Embryonic Stem Cell
Table 6. Key Players of Resident Cardiac Stem Cells
Table 7. Key Players of Umbilical Cord Blood Stem Cells
Table 8. Global Autologous Stem Cell Based Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Autologous Stem Cell Based Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Autologous Stem Cell Based Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Autologous Stem Cell Based Therapies Market Share by Regions (2015-2020)
Table 12. Global Autologous Stem Cell Based Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Autologous Stem Cell Based Therapies Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Autologous Stem Cell Based Therapies Market Growth Strategy
Table 18. Main Points Interviewed from Key Autologous Stem Cell Based Therapies Players
Table 19. Global Autologous Stem Cell Based Therapies Revenue by Players (2015-2020) (Million US$)
Table 20. Global Autologous Stem Cell Based Therapies Market Share by Players (2015-2020)
Table 21. Global Top Autologous Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Stem Cell Based Therapies as of 2019)
Table 22. Global Autologous Stem Cell Based Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Autologous Stem Cell Based Therapies Product Solution and Service
Table 25. Date of Enter into Autologous Stem Cell Based Therapies Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Autologous Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 28. Global Autologous Stem Cell Based Therapies Market Size Share by Type (2015-2020)
Table 29. Global Autologous Stem Cell Based Therapies Revenue Market Share by Type (2021-2026)
Table 30. Global Autologous Stem Cell Based Therapies Market Size Share by Application (2015-2020)
Table 31. Global Autologous Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 32. Global Autologous Stem Cell Based Therapies Market Size Share by Application (2021-2026)
Table 33. North America Key Players Autologous Stem Cell Based Therapies Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Autologous Stem Cell Based Therapies Market Share (2019-2020)
Table 35. North America Autologous Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 36. North America Autologous Stem Cell Based Therapies Market Share by Type (2015-2020)
Table 37. North America Autologous Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 38. North America Autologous Stem Cell Based Therapies Market Share by Application (2015-2020)
Table 39. Europe Key Players Autologous Stem Cell Based Therapies Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Autologous Stem Cell Based Therapies Market Share (2019-2020)
Table 41. Europe Autologous Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Autologous Stem Cell Based Therapies Market Share by Type (2015-2020)
Table 43. Europe Autologous Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Autologous Stem Cell Based Therapies Market Share by Application (2015-2020)
Table 45. China Key Players Autologous Stem Cell Based Therapies Revenue (2019-2020) (Million US$)
Table 46. China Key Players Autologous Stem Cell Based Therapies Market Share (2019-2020)
Table 47. China Autologous Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 48. China Autologous Stem Cell Based Therapies Market Share by Type (2015-2020)
Table 49. China Autologous Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 50. China Autologous Stem Cell Based Therapies Market Share by Application (2015-2020)
Table 51. Japan Key Players Autologous Stem Cell Based Therapies Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Autologous Stem Cell Based Therapies Market Share (2019-2020)
Table 53. Japan Autologous Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Autologous Stem Cell Based Therapies Market Share by Type (2015-2020)
Table 55. Japan Autologous Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Autologous Stem Cell Based Therapies Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Autologous Stem Cell Based Therapies Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Autologous Stem Cell Based Therapies Market Share (2019-2020)
Table 59. Southeast Asia Autologous Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Autologous Stem Cell Based Therapies Market Share by Type (2015-2020)
Table 61. Southeast Asia Autologous Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Autologous Stem Cell Based Therapies Market Share by Application (2015-2020)
Table 63. India Key Players Autologous Stem Cell Based Therapies Revenue (2019-2020) (Million US$)
Table 64. India Key Players Autologous Stem Cell Based Therapies Market Share (2019-2020)
Table 65. India Autologous Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 66. India Autologous Stem Cell Based Therapies Market Share by Type (2015-2020)
Table 67. India Autologous Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 68. India Autologous Stem Cell Based Therapies Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Autologous Stem Cell Based Therapies Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Autologous Stem Cell Based Therapies Market Share (2019-2020)
Table 71. Central & South America Autologous Stem Cell Based Therapies Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Autologous Stem Cell Based Therapies Market Share by Type (2015-2020)
Table 73. Central & South America Autologous Stem Cell Based Therapies Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Autologous Stem Cell Based Therapies Market Share by Application (2015-2020)
Table 75. Regeneus Company Details
Table 76. Regeneus Business Overview
Table 77. Regeneus Product
Table 78. Regeneus Revenue in Autologous Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 79. Regeneus Recent Development
Table 80. Mesoblast Company Details
Table 81. Mesoblast Business Overview
Table 82. Mesoblast Product
Table 83. Mesoblast Revenue in Autologous Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 84. Mesoblast Recent Development
Table 85. Pluristem Therapeutics Inc Company Details
Table 86. Pluristem Therapeutics Inc Business Overview
Table 87. Pluristem Therapeutics Inc Product
Table 88. Pluristem Therapeutics Inc Revenue in Autologous Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 89. Pluristem Therapeutics Inc Recent Development
Table 90. US STEM CELL, INC. Company Details
Table 91. US STEM CELL, INC. Business Overview
Table 92. US STEM CELL, INC. Product
Table 93. US STEM CELL, INC. Revenue in Autologous Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 94. US STEM CELL, INC. Recent Development
Table 95. Brainstorm Cell Therapeutics Company Details
Table 96. Brainstorm Cell Therapeutics Business Overview
Table 97. Brainstorm Cell Therapeutics Product
Table 98. Brainstorm Cell Therapeutics Revenue in Autologous Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 99. Brainstorm Cell Therapeutics Recent Development
Table 100. Tigenix Company Details
Table 101. Tigenix Business Overview
Table 102. Tigenix Product
Table 103. Tigenix Revenue in Autologous Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 104. Tigenix Recent Development
Table 105. Med cell Europe Company Details
Table 106. Med cell Europe Business Overview
Table 107. Med cell Europe Product
Table 108. Med cell Europe Revenue in Autologous Stem Cell Based Therapies Business (2015-2020) (Million US$)
Table 109. Med cell Europe Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autologous Stem Cell Based Therapies Market Share by Type: 2020 VS 2026
Figure 2. Embryonic Stem Cell Features
Figure 3. Resident Cardiac Stem Cells Features
Figure 4. Umbilical Cord Blood Stem Cells Features
Figure 5. Global Autologous Stem Cell Based Therapies Market Share by Application: 2020 VS 2026
Figure 6. Neurodegenerative Disorders Case Studies
Figure 7. Autoimmune Diseases Case Studies
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Autologous Stem Cell Based Therapies Report Years Considered
Figure 10. Global Autologous Stem Cell Based Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Autologous Stem Cell Based Therapies Market Share by Regions: 2020 VS 2026
Figure 12. Global Autologous Stem Cell Based Therapies Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Autologous Stem Cell Based Therapies Market Share by Players in 2019
Figure 15. Global Top Autologous Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Stem Cell Based Therapies as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Autologous Stem Cell Based Therapies Revenue in 2019
Figure 17. North America Autologous Stem Cell Based Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Autologous Stem Cell Based Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Autologous Stem Cell Based Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Autologous Stem Cell Based Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Autologous Stem Cell Based Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Autologous Stem Cell Based Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Autologous Stem Cell Based Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
犬幹細胞治療の世界市場（～2026年） The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…- 幹細胞臍帯血の世界市場（～2026年） Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered uniq…
- 臍帯血幹細胞の世界市場（～2026年） Market Analysis and Insights: Global Cord Blood Stem Cells Market The global Cord Blood Stem Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cord Blood Stem Cells Scope and Market Size Cord Blood Stem Cells marke…
- 造血幹細胞移植（HSCT）の世界市場（～2026年） Market Analysis and Insights: Global Hematopoietic Stem Cell Transplantation (HSCT) Market The global Hematopoietic Stem Cell Transplantation (HSCT) market size is projected to reach US$ 16 million by 2026, from US$ 15 million in 2020, at a CAGR of 7.3%% during 2021-2026. Global Hematopoietic Stem C…
- ヒト間葉系幹細胞（hMSC）の世界市場（～2026年） Human mesenchymal stem cells (hMSC) are multipotent stromal cells that can differentiate into a variety of cell types. Market Analysis and Insights: Global Human Mesenchymal Stem Cells (hMSC) Market The global Human Mesenchymal Stem Cells (hMSC) market size is projected to reach US$ XX million by 20…